Bearing Point Capital LLC Invests $8.93 Million in UnitedHealth Group Incorporated (NYSE:UNH)

Bearing Point Capital LLC purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 17,647 shares of the healthcare conglomerate's stock, valued at approximately $8,927,000. UnitedHealth Group comprises about 1.9% of Bearing Point Capital LLC's investment portfolio, making the stock its 10th biggest position.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Principal Financial Group Inc. boosted its holdings in shares of UnitedHealth Group by 11.3% in the third quarter. Principal Financial Group Inc. now owns 1,778,636 shares of the healthcare conglomerate's stock valued at $1,039,933,000 after acquiring an additional 180,479 shares in the last quarter. Pensionfund Sabic increased its position in UnitedHealth Group by 48.4% during the 4th quarter. Pensionfund Sabic now owns 9,350 shares of the healthcare conglomerate's stock worth $4,730,000 after purchasing an additional 3,050 shares during the period. Kings Path Partners LLC raised its stake in shares of UnitedHealth Group by 11.4% during the 4th quarter. Kings Path Partners LLC now owns 3,300 shares of the healthcare conglomerate's stock worth $1,669,000 after buying an additional 338 shares in the last quarter. Fortem Financial Group LLC grew its holdings in UnitedHealth Group by 16.7% during the fourth quarter. Fortem Financial Group LLC now owns 818 shares of the healthcare conglomerate's stock worth $414,000 after acquiring an additional 117 shares during the period. Finally, Ables Iannone Moore & Associates Inc. lifted its holdings in UnitedHealth Group by 1.0% in the fourth quarter. Ables Iannone Moore & Associates Inc. now owns 3,848 shares of the healthcare conglomerate's stock valued at $1,947,000 after acquiring an additional 37 shares during the period. 87.86% of the stock is owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Down 0.5 %

Shares of UNH stock opened at $398.72 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. The firm has a market cap of $362.92 billion, a P/E ratio of 25.72, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 1-year low of $393.11 and a 1-year high of $630.73. The firm's 50-day simple moving average is $495.85 and its 200-day simple moving average is $528.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. During the same period last year, the business posted $6.91 earnings per share. As a group, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th were given a $2.10 dividend. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a yield of 2.11%. UnitedHealth Group's payout ratio is currently 35.18%.

Analysts Set New Price Targets

Several brokerages recently commented on UNH. Morgan Stanley reduced their price objective on shares of UnitedHealth Group from $664.00 to $563.00 and set an "overweight" rating for the company in a research note on Tuesday, April 22nd. Oppenheimer lowered their price target on UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating on the stock in a report on Monday, April 21st. KeyCorp reduced their price objective on UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating for the company in a report on Monday, April 21st. Hsbc Global Res cut UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research report on Tuesday, April 22nd. Finally, Royal Bank of Canada dropped their target price on shares of UnitedHealth Group from $655.00 to $525.00 and set an "outperform" rating for the company in a report on Wednesday, April 23rd. Four investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group presently has an average rating of "Moderate Buy" and an average price target of $596.86.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.